Oxford Vaccine Effective But Questions On Those Above 55: Report

0
56
While trial results published Tuesday in The Lancet found that a vaccine developed by the University of Oxford and AstraZeneca Plc is safe and effective, more analysis will be needed to see how well it works in people over 55, among those at higher risk from the pandemic.

LEAVE A REPLY

Please enter your comment!
Please enter your name here